Exhibitor

Sekisui XenoTech is a global CRO with over 25 years of unparalleled ADME/DMPK/DDI experience, trusted by 98% of top pharmas and countless other organisations for its proven expertise in vitro ADMET and pharmacology services including screening and definitive enzyme induction and inhibition, drug transporters, reaction phenotyping, etc.; radiolabeling; and in vivo ADMET/PK services such as QWBA, metabolite ID, etc.; bioanalytical services and consultancy.